HomeOpen Access NewsResearch & Innovation

Research & Innovation

Industry-academia collaboration sparks innovation breakthroughs

In the ever-evolving landscape of technological advancement, industry-academia collaboration emerges as a formidable catalyst for innovation breakthroughs.

Nightingale hospitals could increase antibiotic resistance

The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.

Broadening participation in U.S. astronomical research

Open Access Government explores the different ways that the National Science Foundation’s Division of Astronomical Sciences is encouraging wider participation and diversity in U.S. research.

Physics: Crucial questions about structure and our world

Denise Caldwell, Director, Division of Physics U.S. National Science Foundation (NSF), sheds light on research that addresses the most fundamental questions surrounding the structure and inner workings of our world.

Space: Morphology of impact craters from shaped penetrators

Here, M. Danner and R.M Winglee from Department of Earth and Space Sciences at the University of Washington, share their expertise on the morphology of impact craters from shaped penetrators.

£1 million for COVID-19 documentation project in Manchester

The University of Manchester recently won a grant of nearly £1 million, to support their ongoing COVID-19 documentation projection.

Antimicrobial nanocoatings: Functional and preventative benefits

Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that antimicrobial nanocoatings will gain prominence due to their functional and preventative benefits.

One step closer to implanting diagnostic electronics in the body

The American Chemical Society (ACS) are closer to using electronics in the body, to diagnose tumours and track illnesses.

New cell injection technique could reverse vision loss

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.

Male bias in drug development trials creates overmedication

New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.

The science behind the South Korea COVID-19 strategy

Jongeun You explains how the South Korea COVID-19 strategy flattened the curve, without destroying the economy.

World population predicted to shrink after the mid-century

According to a new study, world population will peak in 2064 at around 9.7 billion and then decline to 8.8 billion by 2100 – around 2 billion lower than previous estimates.

Single-cell genomics: Clinical strategies for COVID-19

Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.

Brexit impact: Health and brain research

Prof Monica Di Luca, President, European Brain Council, sheds light on the greater impact of Brexit in terms of health and brain research being up for negotiation.

UK test and trace system not ready for schools to reopen

Researchers say the UK test and trace system needs to improve in four weeks, to prevent a two-times larger COVID second wave.

New blood test could improve detection of Alzheimer’s

A new blood test shows promise in detecting Alzheimer’s as early as 20 years before the onset of cognitive impairment, according to researchers.

21 drugs that could help to treat COVID-19

A study recently identified 21 existing drugs that could improve the effect of remdesivir.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders